Rotarix, Suspension zum Einnehmen
7680601500012
Pharmacode 4890835
CH-60150
J07BH01
08.08.
Reimbursement limitations:
AMLOVALSAND2
Le traitement combiné d’AMLODIPINE VALSARTAN SANDOZ et d'un antagoniste du calcium I.T. 02.06 et/ou d’un …
1 / 3
google
Details
- GTIN
- 7680601500012
- Pharmacode
- 4890835
- Product number
- 6015001
- CPT
- -
- Packaging group
- 1
- Unit
- Einzeldose(n)
- Composition
- Vaccinum attenuatum: rotavirus humanus vivus attenuatum (Stamm: RIX4414) min 1 Mio U., saccharum 1073 mg, dinatrii adipas, Dulbecco's modified eagle medium cum phenylalaninum 15 µg et glucosum 0.01 mg, aqua ad iniectabile q.s. ad suspensionem pro 1.5 ml corresp. natrium 32 mg.
Articles (1)
Rotarix, Suspension zum Einnehmen
suspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
rotavirus humanus vivus attenuatum
|
- | Substance | Wirkstoff (Principe actif) |
|
saccharum
|
1073.0 MG | Substance | HBESI |
|
dinatrii adipas
|
- | Substance | HNIDK |
|
Dulbecco's modified eagle medium
|
- | Substance | HNIDK |
|
phenylalaninum
|
15.0 UG | Substance | HBESI |
|
glucosum
|
0.01 MG | Substance | HBESI |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
32.0 MG | Substance | HBESI |
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 60150
- Drug name
- Rotarix liquid, Suspension zum Einnehmen
- Galenic form
- SUOR
- ATC Code
- J07BH01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 14/05/2009
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ROTARIX liquid susp min 1 Mio U. 1 ml
- Description (DE)
- ROTARIX liquid Susp min 1 Mio U. 1 ml
- Market launch
- 13/03/2017
- Market withdrawal
- 25/11/2019
- Narcotic (BTM)
- No
Application methods
ORA